Studies have shown its potential in promoting glioma cell proliferation by downregulating Max interactor-1 (MXI1), a c-Myc promoter antagonist involved in transcription activation and promoting cell proliferation [11,12,13,14,15,16]. The gene discussed is MXI1; the disease is central nervous system cancer.